{"container_type": "Publication", "source": "AUTHOR_PUBLICATION_ENTRY", "bib": {"title": "Fifteen years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) study: progress and observations from 2,359 older adults spanning the spectrum from cognitive normality to Alzheimer\u2019s disease", "pub_year": 2021, "citation": "Journal of Alzheimer's disease reports 5 (1), 443-468, 2021", "author": "Christopher Fowler and Stephanie R Rainey-Smith and Sabine Bird and Julia Bomke and Pierrick Bourgeat and Belinda M Brown and Samantha C Burnham and Ashley I Bush and Carolyn Chadunow and Steven Collins and James Doecke and Vincent Dor\u00e9 and Kathryn A Ellis and Lis Evered and Amir Fazlollahi and Jurgen Fripp and Samantha L Gardener and Simon Gibson and Robert Grenfell and Elise Harrison and Richard Head and Liang Jin and Adrian Kamer and Fiona Lamb and Nicola T Lautenschlager and Simon M Laws and Qiao-Xin Li and Lucy Lim and Yen Ying Lim and Andrea Louey and S Lance Macaulay and Lucy Mackintosh and Ralph N Martins and Paul Maruff and Colin L Masters and Simon McBride and Lidija Milicic and Madeline Peretti and Kelly Pertile and Tenielle Porter and Morgan Radler and Alan Rembach and Joanne Robertson and Mark Rodrigues and Christopher C Rowe and Rebecca Rumble and Olivier Salvado and Greg Savage and Brendan Silbert and Magdalene Soh and Hamid R Sohrabi and Kevin Taddei and Tania Taddei and Christine Thai and Brett Trounson and Regan Tyrrell and Michael Vacher and Shiji Varghese and Victor L Villemagne and Michael Weinborn and Michael Woodward and Ying Xia and David Ames", "journal": "Journal of Alzheimer's disease reports", "volume": "5", "number": "1", "pages": "443-468", "publisher": "IOS Press", "abstract": "Background: The Australian Imaging, Biomarkers and Lifestyle (AIBL) Study commenced in 2006 as a prospective study of 1,112 individuals (768 cognitively normal (CN), 133 with mild cognitive impairment (MCI), and 211 with Alzheimer\u2019s disease dementia (AD)) as an \u2018Inception cohort\u2019who underwent detailed assessments every 18 months. Over the past decade, an additional 1247 subjects have been added as an \u2018Enrichment cohort\u2019(as of 10 April 2019). Objective: Here we provide an overview of these Inception and Enrichment cohorts of more than 8,500 person-years of investigation.Methods: Participants underwent reassessment every 18 months including comprehensive cognitive testing, neuroimaging (magnetic resonance imaging, MRI; positron emission tomography, PET), biofluid biomarkers and lifestyle evaluations. Results: AIBL has made major contributions to the understanding of the natural history of \u2026"}, "filled": true, "author_pub_id": "DaLwuqYAAAAJ:EUsVPkoNztoC", "num_citations": 49, "citedby_url": "/scholar?hl=en&cites=1340559184806978304", "cites_id": ["1340559184806978304"], "pub_url": "https://content.iospress.com/articles/journal-of-alzheimers-disease-reports/adr210005", "url_related_articles": "/scholar?oi=bibs&hl=en&q=related:AKPO2nmfmhIJ:scholar.google.com/", "cites_per_year": {"2021": 4, "2022": 28, "2023": 17}}